Mitochondrial adaptations to physiological vs. pathological cardiac hypertrophy

被引:207
|
作者
Abel, E. Dale [1 ,2 ]
Doenst, Torsten [3 ]
机构
[1] Univ Utah, Sch Med, Div Endocrinol Metab & Diabet, Salt Lake City, UT 84112 USA
[2] Univ Utah, Sch Med, Program Mol Med, Salt Lake City, UT 84112 USA
[3] Univ Jena, Dept Cardiothorac Surg, D-07747 Jena, Germany
关键词
Cardiac hypertrophy; Mitochondria; Heart failure; Signal transduction; ACTIVATED PROTEIN-KINASE; LEFT-VENTRICULAR HYPERTROPHY; SYMPATHETIC-NERVOUS-SYSTEM; METABOLIC GENE-EXPRESSION; FATTY-ACID-METABOLISM; FAILING HUMAN HEART; OXIDATIVE STRESS; SKELETAL-MUSCLE; CARDIOLIPIN BIOSYNTHESIS; ENERGY-METABOLISM;
D O I
10.1093/cvr/cvr015
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Cardiac hypertrophy is a stereotypic response of the heart to increased workload. The nature of the workload increase may vary depending on the stimulus (repetitive, chronic, pressure, or volume overload). If the heart fully adapts to the new loading condition, the hypertrophic response is considered physiological. If the hypertrophic response is associated with the ultimate development of contractile dysfunction and heart failure, the response is considered pathological. Although divergent signalling mechanisms may lead to these distinct patterns of hypertrophy, there is some overlap. Given the close relationship between workload and energy demand, any form of cardiac hypertrophy will impact the energy generation by mitochondria, which are the key organelles for cellular ATP production. Significant changes in the expression of nuclear and mitochondrially encoded transcripts that impact mitochondrial function as well as altered mitochondrial proteome composition and mitochondrial energetics have been described in various forms of cardiac hypertrophy. Here, we review mitochondrial alterations in pathological and physiological hypertrophy. We suggest that mitochondrial adaptations to pathological and physiological hypertrophy are distinct, and we shall review potential mechanisms that might account for these differences.
引用
收藏
页码:234 / 242
页数:9
相关论文
共 50 条
  • [1] Pathological vs. physiological cardiac hypertrophy
    Kavazis, Andreas N.
    [J]. JOURNAL OF PHYSIOLOGY-LONDON, 2015, 593 (17): : 3767 - 3767
  • [2] Physiological and pathological cardiac hypertrophy
    Shimizu, Ippei
    Minamino, Tohru
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2016, 97 : 245 - 262
  • [3] Mitochondrial biogenesis and energy metabolism in cardiac pathological aversus physiological hypertrophy
    Rimbaud, S.
    Barneoud, L.
    Sanchez, H.
    Fortin, D.
    Veksler, V.
    Bigard, X.
    Ventura-Clapier, R.
    Garnier, A.
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2008, 44 (04) : 813 - 813
  • [4] PHYSIOLOGICAL VS PATHOLOGICAL MYOCARDIAL HYPERTROPHY
    WIKMANCOFFELT, J
    LAKS, MM
    RIEMENSCHNEIDER, T
    MASON, DT
    [J]. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 1978, 10 : 132 - 132
  • [5] Mechanisms of physiological and pathological cardiac hypertrophy
    Nakamura, Michinari
    Sadoshima, Junichi
    [J]. NATURE REVIEWS CARDIOLOGY, 2018, 15 (07) : 387 - 407
  • [6] Mechanisms of physiological and pathological cardiac hypertrophy
    Michinari Nakamura
    Junichi Sadoshima
    [J]. Nature Reviews Cardiology, 2018, 15 : 387 - 407
  • [7] CARDIAC-HYPERTROPHY PROCESS - ANALYSES OF FACTORS DETERMINING PATHOLOGICAL VS PHYSIOLOGICAL DEVELOPMENT
    WIKMANCOFFELT, J
    PARMLEY, WW
    MASON, DT
    [J]. CIRCULATION RESEARCH, 1979, 45 (06) : 697 - 707
  • [8] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Vernon W. Dolinsky
    Carrie-Lynn M. Soltys
    Kyle J. Rogan
    Anita Y. M. Chan
    Jeevan Nagendran
    Shaohua Wang
    Jason R. B. Dyck
    [J]. Journal of Molecular Medicine, 2015, 93 : 413 - 425
  • [9] Resveratrol prevents pathological but not physiological cardiac hypertrophy
    Dolinsky, Vernon W.
    Soltys, Carrie-Lynn M.
    Rogan, Kyle J.
    Chan, Anita Y. M.
    Nagendran, Jeevan
    Wang, Shaohua
    Dyck, Jason R. B.
    [J]. JOURNAL OF MOLECULAR MEDICINE-JMM, 2015, 93 (04): : 413 - 425
  • [10] Transcriptional profiles in physiological and pathological cardiac hypertrophy
    Rodrigo, MC
    Collier, M
    Uezato, H
    Deng, D
    Bristow, J
    Simpson, PC
    [J]. CIRCULATION, 2002, 106 (19) : 34 - 34